生命科学资讯

In the clinic for Feb. 27, 2026

Other news to note for Feb. 27, 2026

Regulatory actions for Feb. 27, 2026

Biopharma money raised: Jan. 1-Feb. 26, 2026

Money raised by biopharma

Moderna’s combination flu, COVID shot wins over European drug regulators

Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design

Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks

Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home

FDA slams ExThera with warning letter over controversial blood filter device

Thermo Fisher extends two leases in Middleton - The Daily Reporter

Ginkgo divests biosecurity arm; J&J's early prostate cancer data

Padcev-Keytruda combo delivers more positive data in bladder cancer

Changing US FDA trial default a global matter

Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge - simplywall.st

Novartis closes Avidity deal as rare heart disease spinout launches

Omics in Orlando Day 2: A Video Report from AGBT - GEN - Genetic Engineering and Biotechnology News

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - PR Newswire

Florida lab uses genome sequencing to diagnose children with rare diseases - Stock Titan

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Yahoo Finance